Barco has put an interactive twist on the fusion of PET and CT data sets. The company demonstrated software at the Society for Imaging Informatics in Medicine meeting (June 7 to 10) that allows the user to blend data from CT and PET data sets to varying degrees, creating images that show more or less anatomic and functional data, at the user’s discretion.
Barco has put an interactive twist on the fusion of PET and CT data sets. The company demonstrated software at the Society for Imaging Informatics in Medicine meeting (June 7 to 10) that allows the user to blend data from CT and PET data sets to varying degrees, creating images that show more or less anatomic and functional data, at the user's discretion.
"This type of viewer allows them to bounce back and forth between the modalities," said Warren Gambella, Barco product logistics manager for advanced visualization.
Data are viewed onscreen in four windows, one showing the hotspots indicated by PET and the other three showing the fused PET and CT data in sagittal, coronal, and axial views. The window showing a PET-only view directs the user's attention to specific points of interest. The other three are tailored interactively by the user to show more or less of the functional or anatomic data as needed to make a diagnosis.
The diagnostician who is most familiar with CT might start with this data set and blend in the PET, Gambella said. Conversely, the PET specialist might begin with PET and blend in CT data.
"Looking at this strictly from a CT standpoint, identifying structural abnormalities and then bouncing on the fly over to the functional imaging allows them to have the best of both worlds," Gambella said.
The software features a 50-50 blend as a happy medium between the two. But an easy-to-use slider offers the means to custom-tailor the visualization to anyone's likings, he said.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.